4-Hydroxy-N-ethyl-N-isobutyltryptamine (4-HO-EiBT, Eibucin) is a substituted tryptamine derivative which acts as a 5-HT2A receptor agonist, with an EC50 of 27.7 nM and an efficacy of 97.5% (vs 5-HT).[1]

See also

References

  1. ^ WO 2023/115167, Banister S, Jorgensen W, Jinlong T, "Compounds", published 2023-06-29, assigned to Psylo Pty Ltd. 


No tags for this post.